New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 29, 2014
UP AFTER EARNINGS: OmniVision (OVTI), up 17.9% after reporting better than expected fourth quarter results and first quarter guidance above expectations... Veeva Systems (VEEV), up 6.2%... Avago (AVGO), up 1.5% after reporting quarterly results... Nimble Storage (NMBL), up 3.76%... ALSO HIGHER: Retrophin (RTRX), up 29.27% following license agreement with Mission Pharmacal for Thiola and revised guidance... (CRM), up 1.75% after announcing global strategic partnership with Microsoft (MSFT). DOWN AFTER EARNINGS: Infoblox (BLOX), down 28.12% after guiding below analyst estimates for fourth quarter and announcing that CEO Robert Thomas is stepping down... Annies (BNNY), down 16.86%... Splunk (SPLK), down 9.15%... Express (EXPR), down 10.27% after reporting quarterly results and announcing that it will close 50 stores over the next 36 months... Lions Gate (LGF), down 5.99%. ALSO LOWER: Glu Mobile (GLUU), down 7.4%.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 >>
November 18, 2015
16:06 EDTCRMSalesforce reports Q3 adjusted EPS 21c, consensus 19c
Subscribe for More Information
14:49 EDTCRMEarnings Watch: Salesforce shares up 14% since last earnings report
Salesforce (CRM) is scheduled to report third quarter results after the market close on Wednesday, November 18, with a conference call scheduled for 5:00 pm ET. Salesforce is a provider of enterprise cloud computing solutions that include apps and platform services. EXPECTATIONS: Analysts are looking for earnings per share of 19c on revenue of $1.7B, according to First Call. The consensus range for EPS is 17c-20c on revenue of $1.68B-$1.72B. On its last earnings conference call, Salesforce gave Q3 EPS guidance of 18c-19c and revenue guidance of $1.69B-$1.7B. It also gave FY16 EPS guidance of 70c-72c and FY16 revenue of $6.6B-$6.63B. The company expects FY16 operating cash flow growth of approximately 34%-35%. Salesforce said it is now on pace to reach $7B run rate later this year. LAST QUARTER: On August 20, Salesforce reported second quarter EPS of 19c, beating the consensus analyst forecast of 18c. The company's revenue came in at $1.63B, topping the consensus estimate of $1.60B. It reported deferred revenue on balance of $3.03B as of July 31 and Q2 subscription and support revenue of $1.52B. Salesforce added that Q2 was the "best quarter ever" for the company due to momentum in Europe and growth in the adoption of its core platform. NEWS: Salesforce and Western Union (WU) announced an agreement for Western Union to use Sales Cloud, Community Cloud, Analytics Cloud and App Cloud to automate previously paper-based processes. Salesforce also announced plans to extend its strategic partnership with Microsoft (MSFT). The company said it would double its workforce in the Seattle area. STREET RESEARCH: Brean Capital said Salesforce should be a core holding due its new cloud targets, operating margin expansion and revenue growth in the 20%-30% range year over year. Jeffries said it was impressed with the company's DreamForce conference, but kept an Underperform rating on the stock because the net present value of new business may be negative for Salesforce at this time. In late September, Oppenheimer said that the company's checks were positive. It added that Salesforce's share of the market could be increasing and adds that Salesforce's platform strategy is becoming more popular with customers. PRICE ACTION: Salesforce shares are up over 14% since the company's Q2 report. In afternoon trading ahead of Thursday's report, Salesforce shares are up fractionally.
14:38 EDTCRMNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Salesforce (CRM), consensus 19c... L Brands (LB), consensus 52c... (CTRP), consensus 9c... NetApp (NTAP), consensus 57c... Keurig Green Mountain (GMCR), consensus 71c.
14:23 EDTCRMSalesforce technical comments ahead of earnings
The stock is trading relatively close to lifetime highs ahead of earnings. The trend has been strongly bullish since January 2012, with price having recently tested near the $80 area, the life high is at $79.82. If the news is a positive surprise, a breakout above the $80 area seems probable, opening up a run to the $85 level. If the news is a bearish disappointment, there is significant support at the $75 area. If that breaks, next support below would be at $73.08 and then at $71.05.
13:47 EDTCRMSalesforce November 77 straddle priced for 7% movement into Q3
Subscribe for More Information
08:16 EDTCRMSalesforce volatility increases into Q3 and outlook
Subscribe for More Information
07:23 EDTSPLKSplunk checks suggest Q3 outperformance, says Stephens
Subscribe for More Information
05:37 EDTCRMStocks with implied volatility above IV index mean; CRM BBY
Subscribe for More Information
November 17, 2015
15:43 EDTCRMStutz leaving Microsoft to join Salesforce, Re/code reports
Subscribe for More Information
09:12 EDTRTRXRetrophin management to meet with Leerink
Subscribe for More Information
08:10 EDTSPLKSplunk volatility elevated into Q3 and outlook
Subscribe for More Information
07:33 EDTSPLKSplunk results should modestly beat expectations, says RBC Capital
Subscribe for More Information
05:43 EDTBLOXInfoblox appoints Ashish Gupta as Chief Marketing Officer
Subscribe for More Information
05:24 EDTCRMStocks with implied volatility above IV index mean; CRM HD
Subscribe for More Information
November 16, 2015
17:10 EDTLGFSoros took stake in Paypal, liquidated Herbalife stake
Soros Fund Management gave a quarterly update on its stakes in a filing this afternoon. NEW STAKES: Paypal (PYPL), CIT Group (CIT), Schlumberger (SLB), Kraft Heinz (KHC), and Amazon (AMZN). INCREASED STAKES: Allergan (AGN), Lions Gate (LGF), Energen (EGN), Southwest Airlines (LUV), and Qunar Cayman Islands (QUNR). DECREASED STAKES: LyondellBasell (LYB), YPF (YPF), Time Warner Cable (TWC), Dow Chemical (DOW), and Monsanto (MON). LIQUIDATED STAKES: Herbalife (HLF), Lennar (LEN), DR Horton (DHI), United Continental (UAL), and Nice Systems (NICE).
15:53 EDTLGFJANA Partners reduces stakes in Rackspace, Qualcomm
JANA Partners gave a quarterly update on its stakes in a filing this afternoon. NEW STAKES: Mattel (MAT), Zoetis (ZTS), and Aramark (ARMK). INCREASED STAKES: ConAgra Foods (CAG). DECREASED STAKES: Rackspace (RAX), Qualcomm (QCOM), Time Warner (TWX), Starz (STRZA), and Lions Gate (LGF). LIQUIDATED STAKES: Johnson Controls (JCI), Precision Castparts (PCP), AerCap Holdings (AER), United Rentals (URI), and HD Supply Holdings (HDS).
10:25 EDTAVGOUBS trims Apple target, says iPhone partner cut production forecast
Hon Hai, which manufactures Apple's (AAPL) iPhones, expects to assemble significantly fewer iPhones this quarter than in the same period in 2014, UBS wrote in a note to investors today. WHAT'S NEW: Hon Hai Precision Industry, also known as Foxconn, is expected to assemble 10% fewer iPhones this quarter than in the same period in 2014, said UBS analyst Steven Milunovich, citing work from fellow UBS analyst Arthur Hsieh. Previously, companies that supply force touch components for iPhones saw a 10%-15% reduction in their orders, the analyst reported. These developments "are not encouraging," but Apple had previously ordered a large number of iPhones for Q4, according to Milunovich. Overall iPhone demand "could still be decent," he believes. However, the analyst lowered his iPhone sales estimate for Apple's March quarter to 61M from 62.5M, asserting that iPhone sales on China's November 11 Singles Day holiday may have come in below expectations. Based on October search volumes, he continues to believe that demand for iPhone units in the fourth quarter of the calendar year will be 75M, in-line with the consensus outlook. Milunovich trimmed his price target on Apple to $140 from $150 but kept a Buy rating on the shares. WHAT'S NOTABLE In a note to investors on November 10, Credit Suisse reported that it was cutting its estimates for 2016 iPhone sales. The firm expects sales of the device to fall 10.4% in the first quarter versus the same period in 2015, and it predicts that iPhone sales will decline 5.5% year-over-year in 2016. Suppliers with greater than 10% exposure to Apple include Avago (AVGO), SanDisk (SNDK), Analog Devices (ADI), Broadcom (BRCM), Texas Instruments (TXN), NXP Semiconductors (NXPI) and Fairchild (FCS), Credit Suisse reported. The firm said it continues to have a negative view of the smartphone sector. PRICE ACTION: In early trading, Apple added nearly 1% to $113.34.
08:09 EDTRTRXRetrophin receives EU ODD for sparsentan
Retrophin announced that the European Commission, or EC, has granted sparsentan orphan drug designation for the treatment of focal segmental glomerulosclerosis, or FSGS. Retrophin previously announced in January 2015 that sparsentan received orphan drug designation from the FDA for the treatment of FSGS. Sparsentan is the company's investigational therapeutic agent which acts as both a potent angiotensin receptor blocker, as well as a selective endothelin receptor antagonist, and is currently being evaluated in the Phase 2 DUET trial in FSGS patients. FSGS is a widely recognized cause of end-stage renal disease and there are no approved pharmacologic treatments currently available in the United States or Europe.
05:30 EDTCRMStocks with implied volatility above IV index mean; ODP CRM
Subscribe for More Information
November 15, 2015
17:09 EDTLGF'Spectre' stays uncatchable while Christmas-themed 'Coopers' outperforms
"Spectre" and "The Peanuts" remained in first and second place, respectively, at the domestic box office while Christmas comedy "Love The Coopers" topped expectations heading into the holiday period. WEEKEND LEADER: Sony's (SNE) "Spectre" grossed $35.4M in the U.S. for the weekend of November 15, falling roughly 50% from its $73M domestic open. Globally speaking, the latest James Bond film has pulled in $543.8M in just its second week at the box office. BOX OFFICE RUNNERS-UP: Fox's (FOX, FOXA) "The Peanuts Movie" earned $24.2M, as Charlie Brown and friends fell somewhat short of analyst expectations for $28.7M. Meanwhile, Lionsgate's (LGF) Christmas-themed comedy "Love The Coopers" debuted at $8.4M, beating estimates of $5.2M-$8M despite harsh reviews. Rounding out the weekend's Top 5 were Fox's "The Martian" with $6.7M and newcomer "The 33" at $5.8M. Analyst expectations ranged $5.5M-$10M for the disaster survival drama from Time Warner's (TWX) Warner Bros.
1 | 2 | 3 | 4 | 5 | 6 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use